Article info
PDFOriginal research
Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research and Treatment EORTC-55971 Cohort
- Correspondence to Dr Lauren Shore Prescott, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, TN 37212, USA; lauren.prescott{at}vumc.org
Citation
Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research and Treatment EORTC-55971 Cohort
Publication history
- Received August 25, 2022
- Accepted October 13, 2022
- First published November 10, 2022.
Online issue publication
January 03, 2023
Article Versions
- Previous version (10 November 2022).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.